Formulation and Drug Delivery

Extruder for Continuous Pharma Processes Performs in R&D and Small-Scale Production

September 14, 2018

Coperion’s ZSK 18 MEGAlab extruder fulfills requirements for both wet extrusion and hot-melt extrusion pharmaceutical processes.

Viewpoint: The Driver of Drug Delivery

September 13, 2018

Advances in medicine and consumer electronics can enhance drug delivery and patient care.

Pall and Aetos Biologics Partner on Biosimilar Manufacturing

September 13, 2018

The collaboration will focus on developing manufacturing solutions for biosimilars.

Biosimilars Battles Heat Up

September 10, 2018

FDA, innovator companies, and biosimilar developers maneuver over exclusivity, naming, interchangeability, and more.

Sanofi Partners with Dyadic to Research Fungus-Based Expression Platform

September 10, 2018

The collaboration will explore the potential of Dyadic’s gene-expression platform to produce multiple biologic vaccines and drugs.

MilliporeSigma Adds CEX Resin and Amino Acids

September 07, 2018

New products were developed as next-generation process intensification technologies, MilliporeSigma reports.

Thermo Fisher Scientific to Acquire Advanced Bioprocessing Business from BD

September 07, 2018

Becton Dickinson’s (BD) Advanced Bioprocessing business will be integrated into Thermo Fisher's Life Sciences Solutions segment.

Hospitals Back Generic Drug Production Venture

September 07, 2018

More than 120 healthcare organizations plan to bring competition to generic drug market.

Study Finds Candidate for Universal Flu Vaccine Protects Against Multiple Strains

September 06, 2018

Research from the Perelman School of Medicine at the University of Pennsylvania suggests that a universal flu vaccine that protects people against most influenza strains is one step closer to reality.

Novartis to Sell Parts of Sandoz in $1-Billion Deal

September 06, 2018

Novartis will sell selected portions of its Sandoz United States portfolio to Aurobindo Pharma USA for $900 million in cash, plus $100 million in potential earn-outs.